Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
06/2007
06/14/2007WO2007048244A3 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides
06/14/2007WO2007047512A3 Inhibition of pax2 by defb1 induction as a therapy for cancer
06/14/2007WO2007035690A3 Methods for diagnosing pancreatic cancer
06/14/2007WO2007030691A3 Antisense antiviral compound and method for treating picornavirus infection
06/14/2007WO2007030576A3 Antisense antiviral compound and method for treating picornavirus infection
06/14/2007WO2007011858A3 Use of adenine as a method for controlling immobilization of nucleic acids on gold surfaces
06/14/2007WO2006135413A3 Encapsidation system for production of recombinant virus-like particles
06/14/2007WO2006133022A3 Compositions and methods for decreasing microrna expression for the treatment of neoplasia
06/14/2007WO2006104749A3 Compositions and methods for detecting compounds that treat a neurological disorder
06/14/2007WO2006051397A8 Oligonucleotide probes
06/14/2007WO2006034507A3 Methods of diagnosing and treating complications of pregnancy
06/14/2007WO2006007558A3 Novel compositions and methods in cancer
06/14/2007WO2006001972A3 Compositions and methods for the diagnosis of group b streptococcus infection
06/14/2007WO2005051308A3 Methods of treating diseases and disorders by targeting multiple kinases
06/14/2007WO2005049848A3 Nucleic acid hybridization methods
06/14/2007WO2004043335A3 Methods of treating infection by drug resistant bacteria
06/14/2007WO2004032847A3 Hepatocyte growth factor variants
06/14/2007WO2000042210A3 Microsatellite dna markers and uses thereof
06/14/2007US20070136897 Nucleic acid molecules encoding hyperactive nucleoside di-phosphate kinase 2 and uses thereof
06/14/2007US20070136892 Process for the production of delta5-unsaturated fatty acids in transgenic organisms
06/14/2007US20070136889 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control
06/14/2007US20070136839 Promoter, promoter control elements, and combinations, and uses thereof
06/14/2007US20070136835 Organisms with elevated levels of gallic acid/polyphenol oxidase and methods of generating such organisms
06/14/2007US20070136833 Genes encoding several poly (ADP-RIBOSE) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith
06/14/2007US20070136832 Novel lipoxygenase proteins and polynucleotides encoding the same
06/14/2007US20070136829 Novel type-1 cytokine receptor glm-r
06/14/2007US20070136827 Cis/trans riboregulators
06/14/2007US20070136826 Anti-mouse CD20 antibodies and uses thereof
06/14/2007US20070136825 Fusion proteins useful for detecting analytes
06/14/2007US20070135672 DNA hybrids and environment cleaning system employing DNA hybrids
06/14/2007US20070135626 Activator bound solid supports for nucleic acid synthesis via the phosphoramidite approach
06/14/2007US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
06/14/2007US20070135372 Modified siRNA molecules and uses thereof
06/14/2007US20070135371 Antisense IAP nucleobase oligomers and uses thereof
06/14/2007US20070135370 siRNA molecule for silencing Ebola virus L-polymerase (L-pol) expression; nucleic acid-lipid particles suitable for use in intravenous nucleic acid delivery as they are stable in circulation, of a size required for pharmacodynamic behavior resulting in access to extravascular sites, and target cell
06/14/2007US20070135364 Compositions and methods for the modulation of the expression of b7 protein
06/14/2007US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders
06/14/2007US20070135344 Novel growth factor and a genetic sequence encoding same
06/14/2007US20070135340 IGF-1 novel peptides
06/14/2007US20070135338 Human GLP-1 mimetibodies, compositions, methods and uses
06/14/2007US20070134772 Thermostable Omega-Transaminases
06/14/2007US20070134771 Thermostable omega-transaminases
06/14/2007US20070134770 Thermostable omega-transaminases
06/14/2007US20070134765 Recombinant bacteria and uses thereof
06/14/2007US20070134764 Endogenous and non-endogenous version of human G protein-coupled receptors
06/14/2007US20070134759 Process for producing antibody composition by using rna inhibiting the function of alpha1,6-fucosyltransferase
06/14/2007US20070134752 Smooth muscle myosin phosphatase associated kinase
06/14/2007US20070134750 Glucose dehydrogenase
06/14/2007US20070134749 Protein tyrosine kinase substrate lat and its use in the identification of (ANT)agonists of the kinase
06/14/2007US20070134727 Antibodies to cytokine receptor
06/14/2007US20070134717 Oxaloacetate hydrolase deficient fungal host cells
06/14/2007US20070134715 Systematic evolution of ligands by exponential enrichment: blended selex
06/14/2007US20070134710 Substrate defining a sample-distribution network having an inlet, detection chambers loaded with detection reagents, and a channel with fluid connections connecting it to the respective detection chambers
06/14/2007US20070134709 Usages of MTHFR gene polymorphisms in predicting homocysteine level, disease risk, and treatment effects and related methods and kit
06/14/2007US20070134708 Diagnostic targets against Johne's disease
06/14/2007US20070134704 Expression vector comprising nucleotide sequences coding fluorescent neurofilament protein (NFP) for diagnostic imaging tool in molecular genetics
06/14/2007US20070134703 Chromophores/fluorophores and methods for using the same
06/14/2007US20070134702 Probe set, probe immobilized carrier and gene examination method
06/14/2007US20070134698 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response
06/14/2007US20070134697 Short interference RNA duplexes, when introduced into mammalian cells in culture, perform sequence-specific inhibition of target mRNA without inducing an interferon response; specific gene silencing
06/14/2007US20070134696 Dispersion of carbon nanotubes by nucleic acids
06/14/2007US20070134686 Methods and compositions for detection of a target nucleic acid sequence utilizing a probe with a 3' flap
06/14/2007US20070134685 For controlling the degree of labeling of carrier molecule or solid support by the addition of reactive label competitor; solid phase synthesis; kits
06/14/2007US20070134683 Probes and methods for identifying polycyclic aromatic hydrocarbon-degrading mycobacteria
06/14/2007US20070134680 Lipid metabolism molecules
06/14/2007US20070134677 Light directed DNA synthesis using inverse capping for error reduction
06/14/2007US20070134659 Polynucleotides for the detection of salmonella species
06/14/2007US20070134656 Product and method
06/14/2007US20070134655 a nucleotide sequence of a first half of said RNA precursor is a partial inversed-reversed sequence of a nucleotide sequence of a second half
06/14/2007US20070134271 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
06/14/2007US20070134270 Chicken rna polymerase i promoter and the use thereof
06/14/2007US20070134263 Grampositive immunogen protein for use in developing vaccine for prevention of microorganismal infection; immunization
06/14/2007US20070134257 Metal-binding therapeutic peptides
06/14/2007US20070134256 Chimpanzee Fab antibodies against DENV-4; isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith
06/14/2007US20070134254 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy
06/14/2007US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
06/14/2007US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
06/14/2007US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
06/14/2007US20070134236 Humanized antibodies against monocyte chemotactric proteins
06/14/2007US20070134234 Immunomodulatory compositions and uses therefor
06/14/2007US20070134229 Non-native constitutively active osteopontin
06/14/2007US20070134227 Catalyst for cleaving sugar chain
06/14/2007US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents
06/14/2007US20070134201 Archaeon expression system
06/14/2007DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy
06/14/2007DE102005058431A1 Nucleic acid useful as a target for detecting species of yeasts and/or filamentous fungi comprises an elongation factor 3 gene or a fragment thereof
06/14/2007CA2642657A1 Method for replicating nucleic acids and novel unnatural base pairs
06/14/2007CA2631952A1 Methods and compositions for needleless delivery of antibodies
06/14/2007CA2629753A1 Process for the preparation of poly(alkoxylated) oligonucleotides
06/13/2007EP1795537A1 Liquid crystalline gel and method for manufacturing the same
06/13/2007EP1795536A1 Phosphoramidite compound and method for producing oligo-rna
06/13/2007EP1795205A2 Method for accessing microbial diversity
06/13/2007EP1794326A2 Use of photopolymerization for amplification and detection of a molecular recognition event
06/13/2007EP1794325A2 Methods for the detection of ovarian cancer
06/13/2007EP1794318A2 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof
06/13/2007EP1794307A2 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
06/13/2007EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor
06/13/2007EP1794174A2 Methods and compositions for inhibition of innate immune responses and autoimmunity
06/13/2007EP1794173A1 Amplification blocker comprising intercalating nucleic acids (tna) containing intercalating pseudonucleotides (ipn)
06/13/2007EP1793864A2 Method of treating an inflammatory disease by double stranded ribonucleic acid